SpikImm

SpikImm has been founded by Truffle Capital and Institut Pasteur. SpikImm’s unique mission is to develop prophylactic mAbs against severe viral diseases in immunocompromised patients. First product is a potent anti-BK virus mAb to protect kidney transplant patients from severe complications caused b... Read more